Skip to Main Content

Spain’s antitrust watchdog has opened an investigation into six large drug makers over long-standing accusations from wholesalers that the companies engage in unfair pricing schemes.

The National Competition and Markets Commission, or CNMC, is actually reviving a 10-year-old case at the direction of Spain’s Supreme Court, which last August ruled that an earlier decision not to pursue an investigation was incorrect. The companies that are under investigation are Pfizer, Merck, Novartis, Sanofi, Eli Lilly, and the Janssen-Cilag unit of Johnson & Johnson.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!